Physiotherapy and specialist input: For persistent or severe back pain, referral to physiotherapy services may be beneficial
24, 2026--Dermavon received the acceptance from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis on 24 February 2026
Patients with lower GLP1R sensitivity may experience milder dysbiosis and need less probiotic support
Greenwood-Van Meerveld et al., "Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus," J
This program offers a low-dose, provider-directed GLP-1 based therapy , helping you sustain your progress while focusing on long-term wellness, balance, and confidence
Stomach acid and pepsin separate the B12 from food proteins